🇺🇸 FDA
Pipeline program

ThisCART22 cells injection

ThisCART22

Phase 1 mab active

Quick answer

ThisCART22 cells injection for B Cell Malignancy is a Phase 1 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
B Cell Malignancy
Phase
Phase 1
Modality
mab
Status
active

Clinical trials